Health ❯ Healthcare

Medical Treatments

Cancer Treatments Gene Therapy Pharmaceuticals Oncology Neurology Immunotherapy Alzheimer's Disease Weight Loss Diabetes Surgery Pharmacology Stem Cell Therapy Surgical Procedures Hyperbaric Oxygen Therapy Hormone Therapy Hormone Replacement Therapy Cannabis Genetic Disorders Obesity Treatments Cell Therapy Cosmetic Procedures Hormonal Treatments Rare Diseases Cancer Treatment Neurological Disorders Antibiotic Therapy Transgender Health Cardiology Pain Management Oxygen Therapy Aesthetic Treatments Pharmacotherapy Radiation Therapy Biotechnology Antibiotics Cancer Therapies Ophthalmology Dialysis Infectious Diseases Cardiovascular Health Hospitalization Migraine Hyperbaric Therapy Injectable Medications In Vitro Fertilization CAR-T Therapy Bariatric Surgery Targeted Therapy Cannabis Therapy Burn Treatment Puberty Blockers Liver Disease Therapeutics Asthma Migraine Treatments Cannabis Use Drug Delivery Drug Approvals Cost of Healthcare Biologics Antimicrobial Treatments Allergic Reactions Dermatology Diabetes Management Prescription Medications Innovative Therapies FDA Approvals Thrombolysis Sleep Disorders Obstructive Sleep Apnea Clinical Trials Chemotherapy Gene Editing Other Conditions Experimental Treatments Emergency Treatments Gender-Transition Treatments Trauma Care Weight Management Weight Loss Treatments Respiratory Conditions Antivenom Development Tattoo Removal Asthma Treatments Stem Cell Transplantation Transfusions Pulmonary Arterial Hypertension Abortion Adolescent Care Risk Assessment Emergency Care Ineffective Therapies Blood Pressure Management Hormonal Therapies Controversial Practices Therapeutic Proteins Anticoagulants Cryotherapy Gender Dysphoria Life-Saving Drugs

LeAnn Rimes Shares $10,000 Plasma Exchange With Stem-Cell Boost From Nashville Clinic

She describes the treatment as a personal wellness choice rather than medical advice.

Bariatric Surgery’s Long-Term Edge Holds Across Social Vulnerability, ARMMS-T2D Analysis Finds

Cochrane Update Finds No Clear Benefit of Cannabis-Based Medicines for Neuropathic Pain

FDA Approves Zycubo, First U.S. Treatment for Menkes Disease

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

FDA Grants Orphan Drug Status to Cellenkos’ CK0804 for Myelofibrosis

Trump Orders Agencies to Fast-Track Marijuana Rescheduling to Schedule III

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

Lancet Phase III Trial Finds Proton Therapy Improves 5-Year Survival in Oropharyngeal Cancer

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients

Early Cilta-Cel Use Linked to Better Outcomes in Relapsed/Refractory Myeloma, ASH 2025 Data Show

FDA Approves Breyanzi for Marginal Zone Lymphoma After Two or More Therapies

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

FDA Approves Durvalumab Added to Perioperative FLOT for Resectable Gastric and GEJ Cancer

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up